Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05023655
Title Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Prisma Health-Upstate
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST